LeonaBio (LONA) Director Joseph Edelman Receives 28,000-Share Option

What Happened

• Joseph Edelman, a director of LeonaBio, was granted a derivative award on 2026-06-23: an option covering 28,000 shares reported at $0.00. The grant is an award under the company’s Outside Director Compensation Policy and is not a sale or cash purchase.

Key Details

• Transaction date: 2026-06-23; Form 4 filed: 2026-06-24 (timely).
• Reported instrument: derivative award (option) for 28,000 shares; reported price $0.00 on the filing.
• Vesting: the option vests on the earlier of (i) June 23, 2027, or (ii) the day before the next annual meeting of stockholders after June 22, 2026 (per footnote).
• Shares owned after transaction: not specified in the provided filing details.
• No 10b5-1, no exercise/sale, and no tax-withholding reported in this transaction.

Context

• This is a routine director compensation grant — not an exercise or sale — and doesn’t indicate an immediate cash commitment or sale of shares. Such awards commonly vest over time and are used to compensate non-employee directors.